trending Market Intelligence /marketintelligence/en/news-insights/trending/cd6qnRTjMjVmZV9iQvFPoA2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

OncBioMune Pharmaceuticals names CEO


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

OncBioMune Pharmaceuticals names CEO

OncBioMune Pharmaceuticals Inc. appointed Brian Barnett to replace Jonathan Head as CEO of the company, effective Dec. 26.

Head will continue to serve as OncBioMune's board chairman and was appointed chief scientific officer.

Before joining OncBioMune, Barnett had served at Puma Biotechnology Inc. as vice president and head of medical affairs since August 2016.

Baton Rouge, La.-based OncBioMune Pharmaceuticals is a clinical-stage biopharmaceutical company that develops cancer immunotherapy products.